These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2571605

  • 21. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI, Smith GW.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
    [Abstract] [Full Text] [Related]

  • 22. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
    Kohli JD, Glock D, Goldberg LI.
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
    [Abstract] [Full Text] [Related]

  • 23. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG, Lefebvre RA, Vanderniepen P.
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [Abstract] [Full Text] [Related]

  • 24. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J.
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [Abstract] [Full Text] [Related]

  • 25. Role of calcium in U 46619 and PGF2 alpha pulmonary vasoconstriction in rat lungs.
    Santoian EC, Angerio AD, Schneidkraut MJ, Ramwell PW, Kot PA.
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H2001-5. PubMed ID: 2603984
    [Abstract] [Full Text] [Related]

  • 26. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ, Apparsundaram S, Lokhandwala MF.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [Abstract] [Full Text] [Related]

  • 27. Human vasodilator responses to a dopamine agonist: possible mechanisms.
    Redman D, Thom SA, Hughes AD, Hasan S, Sever PS.
    J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
    [Abstract] [Full Text] [Related]

  • 28. Response to dopamine agonists of the rat isolated uterus.
    Estañ L, Berenguer A, Martinez-Mir I, Rubio E, Morales-Olivas FJ.
    Gen Pharmacol; 1993 Mar; 24(2):397-401. PubMed ID: 8097743
    [Abstract] [Full Text] [Related]

  • 29. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    Kopia GA, Valocik RE.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
    [Abstract] [Full Text] [Related]

  • 30. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade.
    Martin SW, Broadley KJ.
    Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737
    [Abstract] [Full Text] [Related]

  • 31. Analysis of the agonist activity of fenoldopam (SKF 82526) at the vascular 5-HT2 receptor.
    Christie MI, Harper D, Smith GW.
    Br J Pharmacol; 1992 Dec; 107(4):1008-12. PubMed ID: 1361397
    [Abstract] [Full Text] [Related]

  • 32. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA, Sabouni MH, Ansari AF, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [Abstract] [Full Text] [Related]

  • 33. Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture.
    Bryson SE, Drew GM, Hall AS, Ball SG, Balmforth AJ.
    Eur J Pharmacol; 1992 Jan 14; 225(1):1-5. PubMed ID: 1347268
    [Abstract] [Full Text] [Related]

  • 34. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat.
    Kerns WD, Arena E, Macia RA, Bugelski PJ, Matthews WD, Morgan DG.
    Toxicol Pathol; 1989 Jan 14; 17(1 Pt 2):203-13. PubMed ID: 2568682
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats.
    Häberle DA, Königbauer B.
    J Physiol; 1991 Sep 14; 441():23-34. PubMed ID: 1687747
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man.
    Bakris GL, Weber RR, Nelson K, Elliott WJ, Kaplan E, Murphy MB.
    Miner Electrolyte Metab; 1988 Sep 14; 14(6):343-6. PubMed ID: 2906737
    [Abstract] [Full Text] [Related]

  • 37. Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung.
    Kang KH, Morrow JD, Roberts LJ, Newman JH, Banerjee M.
    J Appl Physiol (1985); 1993 Jan 14; 74(1):460-5. PubMed ID: 8444728
    [Abstract] [Full Text] [Related]

  • 38. Effect of dopamine and a dopamine D-1 receptor agonist on pulsatile thyrotrophin secretion in normal women.
    Boesgaard S, Hagen C, Hangaard J, Andersen AN, Eldrup E.
    Clin Endocrinol (Oxf); 1990 Apr 14; 32(4):423-31. PubMed ID: 1971778
    [Abstract] [Full Text] [Related]

  • 39. Effects of fenoldopam on intracranial pressure and hemodynamic variables at normal and elevated intracranial pressure in anesthetized pigs.
    Hennes HJ, Jantzen JP.
    J Neurosurg Anesthesiol; 1994 Jul 14; 6(3):175-81. PubMed ID: 7915922
    [Abstract] [Full Text] [Related]

  • 40. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    Nichols AJ, Koster PF, Brooks DP, Ruffolo RR.
    J Pharmacol Exp Ther; 1992 Jan 14; 260(1):269-74. PubMed ID: 1346161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.